Physician
Glenoaks Urgent Care Medical Group, INC.
Glenoaks Urgent Care Medical Group, INC. was paid $1.70M by Medicaid between Jan 2018 and Nov 2024, across 71 billing codes. Its largest line is 99203, doctor's office visit, new patient (routine) — 29% of everything it billed.
33Billing provider infoGLENOAKS URGENT CARE MEDICAL GROUP, INC.
GLENDALE, CA 91202
GLENDALE, CA 91202
33aNPI1013097120assigned 10/16/2006
33bProvider typeInternal Medicine Physician
28Total paid$1.70M
24GClaims443,768
24DCodes billed71
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Internal Medicine Physician providers in California
Rank by total paid#87 of 2,679
Median peer was paid$13K
This provider vs. median135×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,755 | $87K | |
| 2019 | 42,528 | $204K | |
| 2020 | 42,095 | $189K | |
| 2021 | 52,076 | $226K | |
| 2022 | 92,519 | $238K | |
| 2023 | 109,370 | $433K | |
| 2024incomplete | 73,425 | $326K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 29% | 46,306 | 44,210 | $497K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 15% | 19,467 | 19,163 | $263K |
| S9083 | Global fee urgent care centers | 15% | 5,649 | 5,350 | $252K |
| 94760 | 9.8% | 77,979 | 73,090 | $168K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.9% | 7,172 | 6,858 | $67K |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 3.6% | 38,154 | 35,942 | $62K |
| 99201 | 2.6% | 745 | 711 | $43K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.3% | 4,646 | 4,438 | $40K |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 2.2% | 21,313 | 20,409 | $37K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.8% | 7,771 | 7,339 | $31K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.7% | 9,563 | 9,155 | $29K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.6% | 505 | 475 | $27K |
59 more codes
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.5% | 14,395 | $25K |
| 71046 | Radiologic examination, chest; 2 views | 1.4% | 5,961 | $23K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 6,786 | $20K |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 1.1% | 13,374 | $18K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.0% | 16,376 | $18K |
| 93000 | <1% | 3,213 | $12K | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 24,665 | $9K |
| 97597 | <1% | 1,187 | $9K | |
| 99406 | <1% | 5,495 | $8K | |
| 81002 | <1% | 9,452 | $7K | |
| 73630 | <1% | 1,307 | $5K | |
| G8484 | Influenza immunization was not administered, reason not given | <1% | 26,203 | $4K |
| 73130 | <1% | 809 | $4K | |
| 29540 | <1% | 658 | $2K | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 28,175 | $2K |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 9,628 | $2K |
| 73610 | <1% | 520 | $2K | |
| 99000 | <1% | 3,929 | $2K | |
| 29280 | <1% | 94 | $2K | |
| 69210 | <1% | 407 | $1K | |
| G8482 | Influenza immunization administered or previously received | <1% | 2,340 | $970.99 |
| 29260 | <1% | 176 | $938.16 | |
| 81025 | <1% | 1,577 | $869.09 | |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | <1% | 3,730 | $855.16 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 411 | $691.57 |
| 73562 | <1% | 147 | $689.32 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,679 | $667.02 |
| 73110 | <1% | 87 | $583.30 | |
| 1036F | <1% | 367 | $444.24 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 966 | $412.74 |
| G8710 | Patient prescribed antibiotic | <1% | 3,458 | $400.00 |
| 82962 | <1% | 1,416 | $378.35 | |
| G8711 | Prescribed antibiotic on or within 3 days after the episode date | <1% | 6,887 | $193.26 |
| 29530 | <1% | 12 | $191.13 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 302 | $181.85 |
| 36415 | Collection of venous blood by venipuncture | <1% | 369 | $173.08 |
| A6454 | Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 791 | $145.32 |
| J1094 | Injection, dexamethasone acetate, 1 mg | <1% | 149 | $143.44 |
| 72100 | <1% | 70 | $137.84 | |
| A6453 | Self-adherent bandage, elastic, non-knitted/non-woven, width less than three inches, per yard | <1% | 1,039 | $86.74 |
| G8708 | Patient not prescribed antibiotic | <1% | 3,284 | $70.00 |
| 73030 | <1% | 26 | $51.72 | |
| 71100 | <1% | 13 | $51.33 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 287 | $42.27 |
| 73140 | <1% | 12 | $15.43 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 319 | $1.90 |
| 86140 | 0% | 16 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 13 | $0.00 |
| 73564 | 0% | 15 | $0.00 | |
| G8712 | Antibiotic not prescribed or dispensed | 0% | 712 | $0.00 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 258 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 719 | $0.00 |
| 86318 | 0% | 14 | $0.00 | |
| 4004F | 0% | 77 | $0.00 | |
| 94060 | 0% | 27 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 16 | $0.00 |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 0% | 29 | $0.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 34 | $0.00 |
| 99401 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPARKER, PETER (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Lake Villa Fire Protection District | Lake Villa, IL | $3.01M |
| Peter Jahangir Parker M D INC. | Glendale, CA | $231K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.